Piramal Pharma, aiming for USD 2 billion revenue by FY30, will invest USD 85 million in capex this fiscal for capacity ...

Piramal Pharma is utilising a capex of about USD 85 million for various initiatives, including capacity expansion, ...

Piramal Pharma shares have shown strong performance across various time frames, delivering a positive return of 39.58% over ...

A capex of about USD 85 million is being utilized by Mumbai-headquartered company, Piramal Pharma, for various initiatives, ...

Piramal Pharma reported a significant increase in consolidated net profit for Q2, growing from Rs 5 crore last year to Rs 23 ...

A part of the capex is planned for the domestic market while some of it would also go into the U.S. business, the chairperson ...

Piramal Pharma's company's revenue for the quarter under review stood at Rs 2,242 crore as compared to Rs 1,911 crore which ...

Piramal Pharma on Thursday reported over four-fold increase in consolidated net profit at Rs 23 crore for the second quarter ...

Revenue from operations rose to ₹2,242 crore in the second quarter as compared with ₹1,911 crore in the year-ago period, ...

Piramal Pharma is investing USD 85 million this fiscal for expansion and maintenance, with USD 30 million already spent in ...

The pharmaceuticals and wellness company reported a four-fold increase in its net profit after tax in its Q2 earnings report.

Piramal Pharma Limited's Chairperson, Nandini Piramal, attributed the company's development to its solid operational ...